Choose Language
Select a language for news translation.
Eli Lilly (NYSE: LLY) is already the leader in the weight-loss market thanks to Zepbound, the best-selling medication in this space. However, the drugmaker has…
If England's obesity rates were still the same as 1993 there would be seven million fewer adults living with obesity. There are 14 million adults classified a…
Scientists have discovered a rare mutation in the FNIP1 gene that functions similarly to the diabetes drug Ozempic, promoting increased calorie burning and red…
Novo Nordisk's shares fell 4.3% after raising its full-year guidance, as investors remain worried about pricing pressures and growth in its obesity drug segmen…
Baron Capital , an investment management company, released its Q2 2026 investor letter for the "Baron Health Care Fund". A copy of the letter is available to d…
A surprisingly small dose of exercise may deliver major health benefits for adults carrying excess fat around the waist. In a four-month trial involving 315 ad…
A daily avocado may help lower heart disease risk in adults with obesity by reducing the number of LDL particles circulating in the blood. After six months, pa…
Written by Matthew Benjamin for The Motley Fool -> Both companies are giants in diabetes and obesity treatments. Lately, Eli Lilly has moved ahead in the obe…
New research challenges the decades-old idea that children experience an “adiposity rebound” when their BMI begins rising around age 6. Although BMI returns to…
Researchers have uncovered a possible biological pathway connecting obesity to Alzheimer’s disease. Obesity appears to raise levels of certain fat molecules th…
